Abiopharma

🔍 Fischer Laurent (Executive)

Company: Adverum Biotechnologies, Inc. (ADVM)

Report Date: 2025-12-05

Detailed Transactions and Holdings:

• Acquired 11,085 shares of Common Stock at $4.24 per share (Direct)
  Date: 2025-12-05 | Code: P | equity_swap_involved: 0 | shares_owned_after: 83,899.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 117,614 shares of Common Stock at $4.31 per share (Direct)
  Date: 2025-12-08 | Code: P | equity_swap_involved: 0 | shares_owned_after: 201,513.00 | transaction_form_type: 4 | Footnotes: F3, F2

Footnotes:

• F1: Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $4.21 to $4.25. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
• F2: Includes 600 shares purchased on May 21, 20125 and 600 shares purchased on November 20, 2025, pursuant to the Issuer's 2014 Employee Stock Purchase Plan, as amended and restated.
• F3: Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $4.25 to $4.32. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.